首页|基于网络药理学探讨人参皂苷Rb1治疗帕金森病的作用机制

基于网络药理学探讨人参皂苷Rb1治疗帕金森病的作用机制

扫码查看
目的:利用网络药理学技术探讨中药人参皂苷Rb1 治疗帕金森病的作用机制,为人参皂苷Rb1 的临床合理应用提供科学理论依据.方法:通过在SwissTargetPrediction、SEA 以及SuperPred数据库中预测人参皂苷Rb1 的靶点;使用关键词"Parkinson Disease"在GeneCards和Omim数据库中获得有关帕金森疾病的相关的靶点;将人参皂苷Rb1 与帕金森病的靶点相互映射,作Veen图,从而获得交集基因;然后使用Cytoscape3.8.2 软件构建"药物-作用靶点"网络;将韦恩图中与帕金森病相关的 21 个共有药物靶点导入String(https://string-db.org/)数据库中,进行蛋白-蛋白相互作用预测,从而预测出核心靶点.将人参皂苷Rb1 治疗帕金森病的核心靶点导入到DAVID数据库中,得到GO分析结果和KEGG富集结果.利用 AutoDock Vina对人参皂苷Rb1 和关键靶点进行分子对接,验证其相互作用活性.结果:人参皂苷Rb1 治疗帕金森病的核心靶点有 4 个,分别为BCL2L1、VEGFA、FGF2、KDR,相关通路 28 条.结合人参皂苷Rb1 的生物学特性,发现人参皂苷Rb1 治疗帕金森病可能是通过PI3K/Akt信号通路参与的生物调节过程,而此调节过程与细胞生物工程中的凋亡的相关机制密切相关.通过关键靶点与人参皂苷Rb1 进行分子对接验证,靶点相互作用结合性高.结论:人参皂苷Rb1 治疗PD可能是通过减少细胞凋亡的生物过程发挥作用,影响的相关的通路有PI3K/Akt信号通路、MAPK信号通路、Notch信号通路,通过与BCL2L1、VEGFA、FGF2、KDR等靶点产生作用.
The mechanism of ginsenoside Rb1 in the treatment of Parkinson's disease based on network pharmacology
Objective:To explore the mechanism of ginsenoside Rb1 in the treatment of Parkinson's disease by u-sing network pharmacology technology,and to provide scientific theoretical basis for the clinical rational application of ginsenoside Rb1.Methods:The targets of ginsenoside Rb1 were predicted in SwissTargetPrediction,SEA and Super-Pred databases.The related targets of Parkinson's disease were obtained in the GeneCards and Omim databases using the keyword'Parkinson Disease'.The ginsenoside Rb1 and the target of Parkinson's disease were mapped to each other,and the Veen diagram was made to obtain the intersection gene.Then,Cytoscape 3.8.2 software was used to construct the'drug-target'network;the 21 common drug targets related to Parkinson's disease in the Venn diagram were imported into the String(https://string-db.org/)database for protein-protein interaction prediction,so as to predict the core tar-gets.The core targets of ginsenoside Rb1 in the treatment of Parkinson's disease were imported into the DAVID database to obtain GO analysis results and KEGG enrichment results.AutoDock Vina was used to perform molecular docking be-tween ginsenoside Rb1 and key targets to verify their interaction activity.Results:There were four core targets of gin-senoside Rb1 in the treatment of Parkinson's disease,namely BCL2L1,VEGFA,FGF2,KDR,with 28 related path-ways.Combined with the biological characteristics of ginsenoside Rb1,it was found that ginsenoside Rb1 treatment of Parkinson's disease mght be involved in the biological regulation process through the PI3K/Akt signaling pathway,and this regulation process was closely related to the mechanism of apoptosis in cell bioengineering.Through the molecular docking verification of the key target and ginsenoside Rb1,the target interaction was highly combined.Conclusion:The mechanism of ginsenoside Rb1 in the treatment of PD may play a role by reducing the biological process of apoptosis.The related pathways affected are PI3K/Akt signaling pathway,MAPK signaling pathway,Notch signaling pathway,and BCL2L1,VEGFA,FGF2,KDR and other targets.

Ginsenoside Rb1Parkinson's diseaseNetwork pharmacologyMolecular docking

祝洪博、代玉晶、赵杰、霍东升

展开 >

包头医学院,内蒙古 包头 014040

人参皂苷Rb1 帕金森病 网络药理学 分子对接

内蒙古自治区自然科学基金内蒙古自治区卫生健康科技计划

2021MS08128202201379

2024

包头医学院学报
内蒙古科技大学包头医学院

包头医学院学报

影响因子:0.543
ISSN:1006-740X
年,卷(期):2024.40(6)